Bryan Reidy
@bryan_reidy
Followers
2K
Following
6K
Media
597
Statuses
4K
๐ซ๐ซ intensivist and anaesthetist | interests in #ECMO, cardiogenic shock, transplant and #QI | he/him ๐ณ๏ธโ๐ | RT โ endorsement ๐ @[email protected]
Dublin City, Ireland
Joined April 2010
For any budding ICU Researchers out there - come work with us! Critical Care Medicine Academic/Clinical Fellowship - (commencing July 2025). Seeย https://t.co/R3GigFFewj Contact aislingmcmahon@mater.ie for further information.
0
5
8
The mass #MEDTwitter exodus to #medsky well and truly underway!
0
0
2
1/ The #Mater Misericordiae University Hospital is currently experiencing a systems problem which means that it cannot access patientsโ Electronic Health Records.
2
6
7
https://t.co/nbgX9Hn5M6 we are recruiting our next SCF @NCCUCambridge. Fantastic opportunity to join our team & develop neurosciences and trauma icm expertise @vfjn2 @Menon_Cambridge @AriErcole @geoghep
0
8
11
At #CCR24 last week one method that came up was the #SlidingDichotomy method. But what is it and when might it be useful? 1/9 #MethodologyMonday #92
2
21
48
Study categorisation from @pocock_stuart at #PratoAnaes2022 โก๏ธ WOW! and PHEW! interpreted the same but very different โก๏ธ PHEW! and DAMN! interpreted differently but virtually the same We need to get wiser, a p-value is no substitute for brain.
1
50
116
I donโt think Rob Mac Sweeney gets enough plaudits for @CritCareReviews - his visionary approach to presenting, discussing, and disseminating new knowledge from critical care trials is ann incredible gift to humankind. Thanks Rob! #ccr24
7
37
144
I like how the 'Monday morning test' has become part and parcel of the discussions at #CCR24. Fascinating to hear how leaders in ICU integrate evidence into clinical practice. @CritCareReviews
1
2
12
Important caveat that some clinical outcomes of relevance (intubation, mortality) were not improved in patients receiving NIV. Health economic and environmental analyses needed. #CCR24
0
1
4
Impressive reduction in progression to severe respiratory failure in patients treated with protocolised early NIV in the #NAVIGATEtrial. #CCR24
1
14
30
I think this has been one of the most robust discussions Iโve heard at any #CCR meetings. Truly awesome. Massive kudos to all @CritCareReviews for creating this forum. #CCR24
1
4
18
Fantastic question about the ethics of when response adaptive randomisation goes wrong. Suitably robust response. Very clear that the @remap_cap authors acutely feel this and have taken great steps to ensure miscoding errors wont occur going forward. #CCR24
0
1
9
Where does this leave steroids for CAP? Results of REMAP-CAP at odds with those of CAPE COD. Meta-analysis required. #CCR24
1
2
12
Since @CritCareReviews and #CCR24 have had a couple of win ratio analyses, hereโs a little plug for a video I made with @CMichaelGibson a few years back that is meant to be an accessible explainer of how it works. Please excuse my hair. It was a different time.
The Win Ratio is being used as the primary endpoint in many ongoing and upcoming randomized trials. @ADAlthousePhD and I demystify the Win Ratio in this short video https://t.co/6NLaSZadiJ
3
29
68
Are all ketones bad? @f_g_zampieri highlighting potential positive effects of ketones in patients with heart failure. Remains to be seen if there are other populations where ketones may improve organ function? https://t.co/VZ7LmVrOFa
#CCR24
ahajournals.org
BACKGROUND: Heart failure triggers a shift in myocardial metabolic substrate utilization, favoring the ketone body 3-hydroxybutyrate as energy source. We hypothesized that 14-day treatment with...
1
1
9
Several people have now raised the questions of the PK/PD properties of SGLT2is in the critically ill. Lots of work to do! #ccr24
0
1
3
@f_g_zampieri : we should revisit the ICU mantra of stopping all the patients home medications when critically unwell #CCR24
0
1
3
This seems to be the original description of the win ratio method. https://t.co/kOp2cExTNJ
#ccr24
pubmed.ncbi.nlm.nih.gov
The conventional reporting of composite endpoints in clinical trials has an inherent limitation in that it emphasizes each patient's first event, which is often the outcome of lesser clinical...
2
0
1